Beta-Amyloid (1-9) – 1 mg

Overview

The Beta-Amyloid (1-9) peptide, available in 1 mg vials, represents a crucial N-terminal fragment of the full-length Alzheimer’s beta-Amyloid peptide. While it lacks the first nine residues found in the peptide sequence from amino acids 1 to 40, it still exhibits the ability to form amyloid fibrils, maintaining its relevance in Alzheimer’s research. This fragment is particularly significant because it contains a functional B cell epitope while lacking known T cell epitopes, making it a promising candidate for the development of beta-Amyloid vaccines that minimize the risk of triggering autoimmune encephalitis.

Key Features

• Derived from the full-length Alzheimer’s beta-Amyloid peptide.
• Retains amyloid fibril formation capabilities.
• Contains a functional B cell epitope.
• Excludes known T cell epitopes.
• Potential use in beta-Amyloid vaccine development.

Specifications

FAQ

What is Beta-Amyloid (1-9) used for?

This peptide is primarily used in Alzheimer’s disease research, particularly in the study of amyloid plaque formation and vaccine development.

How does Beta-Amyloid (1-9) differ from the full-length peptide?

The Beta-Amyloid (1-9) peptide omits the first nine amino acids of the full-length peptide but still retains the ability to form fibrils, crucial for its functionality in research.

Can I order other related peptides?

Yes, we offer a variety of peptides suitable for different research needs. Check out our range of peptides, including PKG Substrate and Autocamtide-2, for your specific applications.

When you choose Beta-Amyloid (1-9), you’re opting for a peptide that plays a key role in understanding Alzheimer’s pathology and vaccine development. Enhance your research with our selection of peptides that are designed for specificity and efficacy.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.